Podcast + Q&A: Combo Product Human Factors Guidance Follows Multi-Year Coalition Effort
This article was originally published in The Gray Sheet
Executive Summary
Combination Products Coalition's Bradley Thompson discusses how the organization lobbied for changes to FDA's review process to bring more consistency in human factors requirements for combination products, resulting in a recent draft guidance document. Listen to the "Gray Sheet" podcast interview and read the Q&A.
You may also be interested in...
FDA Guidance Sheds Light On Human Factor Studies For Combo Products
Questions from companies and FDA reviewers about human factor design and data requirements for combination products continue to grow. In response, the agency has issued a draft guidance.
Combo Product Reforms Are A Priority For Next User Fee Round, FDA Officials Say
Top FDA officials, including CDRH Director Jeffrey Shuren and FDA Deputy Commissioner Robert Califf, are sending strong signals that the designation and review processes for combination products are due for a significant reassessment. That should be a priority topic of upcoming user fee negotiations with industry, they say.
Human Factors Questions Drive Rise In FDA Inter-Center Consults
Formal consultations between FDA's product centers are becoming more frequent, and they are often triggered by questions about human factors issues, says Office of Combination Products Director Thinh Nguyen.